Pediatric modification of the Montreal classification for inflammatory bowel disease: The Paris classification

Inflammatory Bowel Diseases

Volumn 17, Issue 6, 2011, Pages 1314-1321

  Levine, Arie ^a   Griffiths, Anne ^b   Markowitz, James ^c   Wilson, David C ^d   Turner, Dan ^e   Russell, Richard K ^f   Fell, John ^g   Ruemmele, Frank M ^h   Walters, Thomas ^b   Sherlock, Mary ^b   Dubinsky, Marla ⁱ   Hyams, Jeffrey S ^j  

^a TEL AVIV UNIVERSITY   (Israel)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c Division of Pediatric Hematology Oncology and Stem Cell Transplantation   (United States)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

^e SHAARE ZEDEK MEDICAL CENTER   (Israel)

^f ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^g IMPERIAL COLLEGE LONDON   (United Kingdom)

^h UNIVERSITÉ PARIS DESCARTES   (France)

ⁱ CHILDREN S HOSPITAL LOS ANGELES   (United States)

^j Division of Infectious Diseases and Immunology   (United States)

more..

Author keywords

children; Crohn's disease; inflammatory bowel disease; phenotypes; ulcerative colitis

Indexed keywords

ANTIBODY; IMMUNOSUPPRESSIVE AGENT; SACCHAROMYCES CEREVISIAE ANTIBODY; UNCLASSIFIED DRUG;

ARTICLE; CHILDHOOD DISEASE; CROHN DISEASE; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE DURATION; ENTERITIS; FRANCE; GROWTH DISORDER; HISTOLOGY; HUMAN; ILEUM; IMMUNOSUPPRESSIVE TREATMENT; MONTREAL CLASSIFICATION; ONSET AGE; PHENOTYPE; PRIORITY JOURNAL; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGE FACTORS; AGE OF ONSET; CHILD; CHILD, PRESCHOOL; COLITIS, ULCERATIVE; CROHN DISEASE; DISEASE PROGRESSION; HUMANS; INFANT; INFLAMMATORY BOWEL DISEASES; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 79955712974     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21493     Document Type: Article

References (65)

1. Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005; 19 (suppl A): 5-36.
2. Bousvaros A, Antonioli DA, Colletti RB, et al. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America. J Pediatr Gastroenterol Nutr. 2007; 44: 653-674.
3. Rajwal SR, Puntis JW, McClean P, et al. Endoscopic rectal sparing in children with untreated ulcerative colitis. J Pediatr Gastroenterol Nutr. 2004; 38: 66-69. (Pubitemid 39274470)
4. Markowitz J, Kahn E, Grancher K, et al. Atypical rectosigmoid histology in children with newly diagnosed ulcerative colitis. Am J Gastroenterol. 1993; 88: 2034-2037. (Pubitemid 23352167)
5. Kim B, Barnett JL, Kleer CG, et al. Endoscopic and histological patchiness in treated ulcerative colitis. Am J Gastroenterol. 1999; 94: 3258-3262.
6. Bernstein CN, Shanahan F, Anton PA, et al. Patchiness of mucosal inflammation in treated ulcerative colitis: a prospective study. Gastrointest Endosc. 1995; 42: 232-237.
7. Washington K, Greenson JK, Montgomery E, et al. Histopathology of ulcerative colitis in initial rectal biopsy in children. Am J Surg Pathol. 2002; 26: 1441-1449. (Pubitemid 35239420)
8. Xin W, Brown PI, Greenson JK., The clinical significance of focal active colitis in pediatric patients. Am J Surg Pathol. 2003; 27: 1134-1138. (Pubitemid 36909535)
9. Dendrinos K, Cerda S, Farraye FA., The "cecal patch" in patients with ulcerative colitis. Gastrointest Endosc. 2008; 68: 1006-1007.
10. Joo M, Abreu-e-Lima P, Farraye F, et al. Pathologic features of ulcerative colitis in patients with primary sclerosing cholangitis: a case-control study. Am J Surg Pathol. 2009; 33: 854-862.
11. Dolz C, Vilella A, Andreu H, Riera J., Ulcerative colitis with segmental involvement. Gastroenterol Hepatol. 2003; 26: 64-69. (Pubitemid 36182111)
12. Glickman JN, Bousvaros A, Farraye FA, et al. Pediatric patients with untreated ulcerative colitis may present initially with unusual morphologic findings. Am J Surg Pathol. 2004; 28: 190-197. (Pubitemid 38124727)
13. Turner D, Griffiths AM., Esophageal, gastric, and duodenal manifestations of IBD and the role of upper endoscopy in IBD diagnosis. Curr Gastroenterol Rep. 2009; 11: 234-237.
14. Ruuska T, Vaajalahti P, Arajarvi P, et al. Prospective evaluation of upper gastrointestinal mucosal lesions in children with ulcerative colitis and Crohn's disease. J Pediatr Gastroenterol Nutr. 1994; 19: 181-186. (Pubitemid 24299627)
15. Parente F, Cucino C, Bollani S, et al. Focal gastric inflammatory infiltrates in inflammatory bowel diseases: prevalence, immunohistochemical characteristics, and diagnostic role. Am J Gastroenterol. 2000; 95: 705-711. (Pubitemid 30123906)
16. Schmidt-Sommerfeld E, Kirschner BS, Stephens JK., Endoscopic and histologic findings in the upper gastrointestinal tract of children with Crohn's disease. J Pediatr Gastroenterol Nutr. 1990; 11: 448-454. (Pubitemid 20374626)
17. Sharif F, McDermott M, Dillon M, et al. Focally enhanced gastritis in children with Crohn's disease and ulcerative colitis. Am J Gastroenterol. 2002; 97: 1415-1420. (Pubitemid 34664786)
18. Oberhuber G, Hirsch M, Stolte M., High incidence of upper gastrointestinal tract involvement in Crohn's disease. Virchows Arch. 1998; 432: 49-52. (Pubitemid 28067405)
19. Yantiss RK, Farraye FA, O'Brien MJ, et al. Prognostic significance of superficial fissuring ulceration in patients with severe " indeterminate" colitis. Am J Surg Pathol. 2006; 30: 165-170. (Pubitemid 43740184)
20. Goldstein N, Dulai M., Contemporary morphologic definition of backwash ileitis in ulcerative colitis and features that distinguish it from Crohn disease. Am J Clin Pathol. 2006; 126: 365-376. (Pubitemid 44338788)
21. Haskell H, Andrews CW Jr, Reddy SI, et al. Pathologic features and clinical significance of "backwash" ileitis in ulcerative colitis. Am J Surg Pathol. 2005; 29: 1472-1481. (Pubitemid 41513297)
22. Laghi A, Borrelli O, Paolantonio P, et al. Contrast enhanced magnetic resonance imaging of the terminal ileum in children with Crohn's disease. Gut. 2003; 52: 393-397. (Pubitemid 36250060)
23. Mamula P, Telega GW, Markowitz JE, et al. Inflammatory bowel disease in children 5 years of age and younger. Am J Gastroenterol. 2002; 97: 2005-2010.
24. Heyman MB, Kirschner BS, Gold BD, et al. Children with early-onset inflammatory bowel disease (IBD): analysis of a pediatric IBD consortium registry. J Pediatr. 2005; 146: 35-40. (Pubitemid 40091728)
25. Levine A, Kugathasan S, Annese V, et al. Pediatric onset Crohn's colitis is characterized by genotype-dependent age-related susceptibility. Inflamm Bowel Dis. 2007; 13: 1509-1515.
26. Meinzer U, Idestrom M, Alberti C, et al. Ileal involvement is age dependent in pediatric Crohn's disease. Inflamm Bowel Dis. 2005; 11: 639-644. (Pubitemid 40961077)
27. Markowitz J, Kugathasan S, Dubinsky M, et al. Age of diagnosis influences serologic responses in children with Crohn's disease: a possible clue to etiology ? Inflamm Bowel Dis. 2009; 15: 714-719.
28. Shaoul R, Karban A, Reif S, et al. Disease behavior in children with Crohn's disease: the effect of disease duration, ethnicity, genotype, and phenotype. Dig Dis Sci. 2009; 54: 142-150.
29. Van Limbergen J, Russell RK, Drummond HE, et al. Definition of phenotypic characteristics of childhood-onset inflammatory bowel disease. Gastroenterology. 2008; 135: 1114-1122.
30. Karban A, Itay M, Davidovich O, et al. Risk factors for perianal Crohn's disease: the role of genotype, phenotype, and ethnicity. Am J Gastroenterol. 2007; 102: 1702-1708. (Pubitemid 47206693)
31. Tarrant KM, Barclay ML, Frampton CM, et al. Perianal disease predicts changes in Crohn's disease phenotype-results of a population-based study of inflammatory bowel disease phenotype. Am J Gastroenterol. 2008; 103: 3082-3093.
32. Vernier-Massouille G, Balde M, Salleron J, et al. Natural history of pediatric Crohn's disease: a population-based cohort study. Gastroenterology. 2008; 135: 1106-1113.
33. Cannioto Z, Berti I, Martelossi S, et al. IBD and IBD mimicking enterocolitis in children younger than 2 years of age. Eur J Pediatr. 2009; 168: 149-155.
34. Ruemmele FM, El Khoury MG, Talbotec C, et al. Characteristics of inflammatory bowel disease with onset during the first year of life. J Pediatr Gastroenterol Nutr. 2006; 43: 603-609. (Pubitemid 44863685)
35. Glocker EO, Kotlarz D, Boztug K, et al. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N Engl J Med. 2009; 361: 2033-2045.
36. Lazarev M, Hutfless S, Bitton A, et al. Divergence in L4 Crohn's disease: jejunal, not esophagogastroduodenal involvement, is portective of L2 disease location, and a risk for stricturing behavior and multiple abdominal surgeries. Report from the NIDDK-IBDGC Registry. Presented at Digestive Disease Week, New Orleans, May 2010 (abstract 760).
37. Sawczenko A, Sandhu BK., Presenting features of inflammatory bowel disease in Great Britain and Ireland. Arch Dis Child. 2003; 88: 995-1000. (Pubitemid 37449406)
38. Babusukumar U, Wang T, McGuire E, et al. Contribution of OCTN variants within the IBD5 locus to pediatric onset Crohn's disease. Am J Gastroenterol. 2006; 101: 1354-1361. (Pubitemid 43830005)
39. Russell RK, Drummond HE, Nimmo ER, et al. Analysis of the influence of OCTN1/2 variants within the IBD5 locus on disease susceptibility and growth indices in early onset inflammatory bowel disease. Gut. 2006; 55: 1114-1123. (Pubitemid 44085677)
40. Lenaerts C, Roy CC, Vaillancourt M, et al. High incidence of upper gastrointestinal tract involvement in children with Crohn disease. Pediatrics. 1989; 83: 777-781. (Pubitemid 19120523)
41. van Hogezand RA, Witte AM, Veenendaal RA, et al. Proximal Crohn's disease: review of the clinicopathologic features and therapy. Inflamm Bowel Dis. 2001; 7: 328-3237.
42. Lemberg DA, Clarkson CM, Bohane TD, et al. Role of esophagogastroduodenoscopy in the initial assessment of children with inflammatory bowel disease. J Gastroenterol Hepatol. 2005; 20: 1696-1700. (Pubitemid 43961075)
43. Kundhal PS, Stormon MO, Zachos M, et al. Gastral antral biopsy in the differentiation of pediatric colitides. Am J Gastroenterol. 2003; 98: 557-561. (Pubitemid 36348525)
44. Kaufman SS, Vanderhoof JA, Young R, et al. Gastroenteric inflammation in children with ulcerative colitis. Am J Gastroenterol. 1997; 92: 1209-1212. (Pubitemid 27304825)
45. Castellaneta SP, Afzal NA, Greenberg M, et al. Diagnostic role of upper gastrointestinal endoscopy in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2004; 39: 257-261.
46. Tobin JM, Sinha B, Ramani P, et al. Upper gastrointestinal mucosal disease in pediatric Crohn disease and ulcerative colitis: a blinded, controlled study. J Pediatr Gastroenterol Nutr. 2001; 32: 443-448. (Pubitemid 32488302)
47. Mack DR, Markowitz J, Lerer T, et al. Upper gastrointestinal involvement in pediatric Crohn's disease: experience of a large multicenter inception cohort. Presented at Digestive Disease Week, New Orleans, May 2010 (abstract S1189).
48. Rubio CA, Orrego A, Nesi G, et al. Frequency of epithelioid granulomas in colonoscopic biopsy specimens from paediatric and adult patients with Crohn's colitis. J Clin Pathol. 2007; 60: 1268-1272. (Pubitemid 350084550)
49. Heresbach D, Alexandre JL, Branger B, et al. Frequency and significance of granulomas in a cohort of incident cases of Crohn's disease. Gut. 2005; 54: 215-222. (Pubitemid 40139236)
50. Inflammatory bowel disease in children and adolescents: recommendations for diagnosisâthe Porto criteria. J Pediatr Gastroenterol Nutr. 2005; 41: 1-7.
51. Gower-Rousseau C, Dauchet L, Vernier-Massouille G, et al. The natural history of pediatric ulcerative colitis: a population-based cohort study. Am J Gastroenterol. 2009; 104: 2080-2088.
52. Romberg-Camps MJ, Dagnelie PC, Kester AD, et al. Influence of phenotype at diagnosis and of other potential prognostic factors on the course of inflammatory bowel disease. Am J Gastroenterol. 2009; 104: 371-383.
53. Solberg IC, Lygren I, Jahnsen J, et al. Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study). Scand J Gastroenterol. 2009; 44: 431-440.
54. Cosnes J, Cattan S, Blain A, et al. Long-term evolution of disease behavior of Crohn's disease. Inflamm Bowel Dis. 2002; 8: 244-250. (Pubitemid 34784976)
55. Dubinsky MC, Kugathasan S, Mei L, et al. Increased immune reactivity predicts aggressive complicating Crohn's disease in children. Clin Gastroenterol Hepatol. 2008; 6: 1105-1111.
56. Oberhuber G, Stangl PC, Vogelsang H, et al. Significant association of strictures and internal fistula formation in Crohn's disease. Virchows Arch. 2000; 437: 293-297.
57. Kahn E, Markowitz J, Blomquist K, et al. The morphologic relationship of sinus and fistula formation to intestinal stenoses in children with Crohn's disease. Am J Gastroenterol. 1993; 88: 1395-1398. (Pubitemid 23259513)
58. Turner D, Otley AR, Mack D, et al. Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study. Gastroenterology. 2007; 133: 423-432. (Pubitemid 47193130)
59. Turner D, Walsh CM, Benchimol EI, et al. Severe paediatric ulcerative colitis: incidence, outcomes and optimal timing for second-line therapy. Gut. 2008; 57: 331-338. (Pubitemid 351288098)
60. Turner D, Mack D, Leleiko N, et al. Severe pediatric ulcerative colitis: a prospective multicenter study of outcomes and predictors of response. Gastroenterology. 2010; 138: 2282-2291.
61. Louis E, Collard A, Oger AF, et al. Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease. Gut. 2001; 49: 777-782. (Pubitemid 33096034)
62. Hyams J, Davis P, Lerer T, et al. Clinical outcome of ulcerative proctitis in children. J Pediatr Gastroenterol Nutr. 1997; 25: 149-152. (Pubitemid 27311376)
63. Walters TD, Griffiths AM., Mechanisms of growth impairment in pediatric Crohn's disease. Nat Rev Gastroenterol Hepatol. 2009; 6: 513-523.
64. Heuschkel R, Salvestrini C, Beattie RM, et al. Guidelines for the management of growth failure in childhood inflammatory bowel disease. Inflamm Bowel Dis. 2008; 14: 839-849. (Pubitemid 351898069)
65. Rogol AD, Roemmich JN, Clark PA., Growth at puberty. J Adolesc Health. 2002; 31 (6 suppl): 192-200. (Pubitemid 35434159)